Trial Profile
A retrospective study investigating the risk factors associated with intravenous administration of linezolid that might lead to development of thrombocytopenia in Japanese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections; Staphylococcal infections; Vancomycin-resistant enterococcal infections
- Focus Adverse reactions
- 10 Feb 2016 New trial record